the research council for complementary medicine
the research council for complementary medicine Company Information
Company Number
07864912
Next Accounts
Dec 2025
Industry
Other human health activities
Shareholders
-
Group Structure
View All
Contact
Registered Address
33 kenway road, london, SW5 0RP
Website
www.rccm.org.ukthe research council for complementary medicine Estimated Valuation
Pomanda estimates the enterprise value of THE RESEARCH COUNCIL FOR COMPLEMENTARY MEDICINE at £53.8k based on a Turnover of £120.3k and 0.45x industry multiple (adjusted for size and gross margin).
the research council for complementary medicine Estimated Valuation
Pomanda estimates the enterprise value of THE RESEARCH COUNCIL FOR COMPLEMENTARY MEDICINE at £11.1k based on an EBITDA of £3.3k and a 3.42x industry multiple (adjusted for size and gross margin).
the research council for complementary medicine Estimated Valuation
Pomanda estimates the enterprise value of THE RESEARCH COUNCIL FOR COMPLEMENTARY MEDICINE at £54.4k based on Net Assets of £22.2k and 2.46x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
The Research Council For Complementary Medicine Overview
The Research Council For Complementary Medicine is a live company located in london, SW5 0RP with a Companies House number of 07864912. It operates in the other human health activities sector, SIC Code 86900. Founded in November 2011, it's largest shareholder is unknown. The Research Council For Complementary Medicine is a established, micro sized company, Pomanda has estimated its turnover at £120.3k with healthy growth in recent years.
Upgrade for unlimited company reports & a free credit check
The Research Council For Complementary Medicine Health Check
Pomanda's financial health check has awarded The Research Council For Complementary Medicine a 3 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 6 areas for improvement. Company Health Check FAQs
3 Strong
1 Regular
6 Weak
Size
annual sales of £120.3k, make it smaller than the average company (£689.3k)
- The Research Council For Complementary Medicine
£689.3k - Industry AVG
Growth
3 year (CAGR) sales growth of 12%, show it is growing at a faster rate (7.1%)
- The Research Council For Complementary Medicine
7.1% - Industry AVG
Production
with a gross margin of 21.2%, this company has a higher cost of product (36.6%)
- The Research Council For Complementary Medicine
36.6% - Industry AVG
Profitability
an operating margin of 2.7% make it less profitable than the average company (5.1%)
- The Research Council For Complementary Medicine
5.1% - Industry AVG
Employees
with 2 employees, this is below the industry average (18)
- The Research Council For Complementary Medicine
18 - Industry AVG
Pay Structure
on an average salary of £25.9k, the company has an equivalent pay structure (£25.9k)
- The Research Council For Complementary Medicine
£25.9k - Industry AVG
Efficiency
resulting in sales per employee of £60.2k, this is more efficient (£45.3k)
- The Research Council For Complementary Medicine
£45.3k - Industry AVG
Debtor Days
it gets paid by customers after 70 days, this is later than average (20 days)
- The Research Council For Complementary Medicine
20 days - Industry AVG
Creditor Days
its suppliers are paid after 4 days, this is quicker than average (17 days)
- The Research Council For Complementary Medicine
17 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- The Research Council For Complementary Medicine
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - The Research Council For Complementary Medicine
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 4.8%, this is a lower level of debt than the average (22%)
4.8% - The Research Council For Complementary Medicine
22% - Industry AVG
THE RESEARCH COUNCIL FOR COMPLEMENTARY MEDICINE financials
The Research Council For Complementary Medicine's latest turnover from March 2024 is estimated at £120.3 thousand and the company has net assets of £22.2 thousand. According to their latest financial statements, we estimate that The Research Council For Complementary Medicine has 2 employees and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | ||||||||||||
| Other Income Or Grants | ||||||||||||
| Cost Of Sales | ||||||||||||
| Gross Profit | ||||||||||||
| Admin Expenses | ||||||||||||
| Operating Profit | ||||||||||||
| Interest Payable | ||||||||||||
| Interest Receivable | ||||||||||||
| Pre-Tax Profit | ||||||||||||
| Tax | ||||||||||||
| Profit After Tax | ||||||||||||
| Dividends Paid | ||||||||||||
| Retained Profit | ||||||||||||
| Employee Costs | ||||||||||||
| Number Of Employees | ||||||||||||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 210 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 93 | 0 |
| Total Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 93 | 210 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Debtors | 23,273 | 20,715 | 18,377 | 16,378 | 16,318 | 19,151 | 24,095 | 23,667 | 0 | 0 | 0 | 0 |
| Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 14,690 | 12,595 | 12,857 | 7,998 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 23,273 | 20,715 | 18,377 | 16,378 | 16,318 | 19,151 | 24,095 | 23,667 | 14,690 | 12,595 | 12,857 | 7,998 |
| total assets | 23,273 | 20,715 | 18,377 | 16,378 | 16,318 | 19,151 | 24,095 | 23,667 | 14,690 | 12,595 | 12,950 | 8,208 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 1,120 | 1,000 | 1,103 | 1,000 | 1,000 | 1,635 | 1,708 | 0 | 2,552 | 3,420 | 285 | 137 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current liabilities | 1,120 | 1,000 | 1,103 | 1,000 | 1,000 | 1,635 | 1,708 | 0 | 2,552 | 3,420 | 285 | 137 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1,515 | 0 | 0 | 0 | 0 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1,515 | 0 | 0 | 0 | 0 |
| total liabilities | 1,120 | 1,000 | 1,103 | 1,000 | 1,000 | 1,635 | 1,708 | 1,515 | 2,552 | 3,420 | 285 | 137 |
| net assets | 22,153 | 19,715 | 17,274 | 15,378 | 15,318 | 17,516 | 22,387 | 22,152 | 12,138 | 9,175 | 12,665 | 8,071 |
| total shareholders funds | 22,153 | 19,715 | 17,274 | 15,378 | 15,318 | 17,516 | 22,387 | 22,152 | 12,138 | 9,175 | 12,665 | 8,071 |
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||
| Operating Profit | ||||||||||||
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | ||||||||||||
| Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors | 2,558 | 2,338 | 1,999 | 60 | -2,833 | -4,944 | 428 | 23,667 | 0 | -93 | 93 | 0 |
| Creditors | 120 | -103 | 103 | 0 | -635 | -73 | 1,708 | -2,552 | -868 | 3,135 | 148 | 137 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | ||||||||||||
| Investing Activities | ||||||||||||
| capital expenditure | ||||||||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | ||||||||||||
| Financing Activities | ||||||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | -1,515 | 1,515 | 0 | 0 | 0 | 0 |
| share issue | ||||||||||||
| interest | ||||||||||||
| cash flow from financing | ||||||||||||
| cash and cash equivalents | ||||||||||||
| cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -14,690 | 2,095 | -262 | 4,859 | 7,998 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -14,690 | 2,095 | -262 | 4,859 | 7,998 |
the research council for complementary medicine Credit Report and Business Information
The Research Council For Complementary Medicine Competitor Analysis
Perform a competitor analysis for the research council for complementary medicine by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other micro companies, companies in SW5 area or any other competitors across 12 key performance metrics.
the research council for complementary medicine Ownership
THE RESEARCH COUNCIL FOR COMPLEMENTARY MEDICINE group structure
The Research Council For Complementary Medicine has no subsidiary companies.
Ultimate parent company
THE RESEARCH COUNCIL FOR COMPLEMENTARY MEDICINE
07864912
the research council for complementary medicine directors
The Research Council For Complementary Medicine currently has 10 directors. The longest serving directors include Dr Carol Granger (Sep 2012) and Dr John Hughes (Jun 2014).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Dr Carol Granger | England | 65 years | Sep 2012 | - | Director |
| Dr John Hughes | England | 52 years | Jun 2014 | - | Director |
| Ms Patricia North | England | 64 years | Jul 2016 | - | Director |
| Ms Ava Lorenc | England | 43 years | Mar 2019 | - | Director |
| Ms Jennifer Hill | United Kingdom | 39 years | Aug 2019 | - | Director |
| Ms Jennifer Barnes | United Kingdom | 39 years | Aug 2019 | - | Director |
| Miss Lianne Aquilina | 44 years | Mar 2020 | - | Director | |
| Ms Zetta Thomelin | England | 59 years | Jul 2020 | - | Director |
| Mrs Patricia-Anne Cook | England | 74 years | Jan 2024 | - | Director |
| Ms Karen Charlesworth | England | 57 years | Mar 2024 | - | Director |
P&L
March 2024turnover
120.3k
+23%
operating profit
3.3k
0%
gross margin
21.2%
+2.86%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2024net assets
22.2k
+0.12%
total assets
23.3k
+0.12%
cash
0
0%
net assets
Total assets minus all liabilities
the research council for complementary medicine company details
company number
07864912
Type
Private Limited by guarantee without Share Capital Exempt from using Limited
industry
86900 - Other human health activities
incorporation date
November 2011
age
13
incorporated
UK
ultimate parent company
accounts
Micro-Entity Accounts
last accounts submitted
March 2024
previous names
N/A
accountant
-
auditor
-
address
33 kenway road, london, SW5 0RP
Bank
-
Legal Advisor
-
the research council for complementary medicine Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to the research council for complementary medicine.
the research council for complementary medicine Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for THE RESEARCH COUNCIL FOR COMPLEMENTARY MEDICINE. This can take several minutes, an email will notify you when this has completed.
the research council for complementary medicine Companies House Filings - See Documents
| date | description | view/download |
|---|
